title: Phase II study of erlotinib in Japanese patients with advanced non-small cell lung cancer.
authors.affiliation: Division of Thoracic Oncology, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka 411-8777, Japan. t.takahashi@scchr.jp
authors.forename: Toshiaki
authors.initials: T
authors.lastname: Takahashi
authors.forename: Nobuyuki
authors.initials: N
authors.lastname: Yamamoto
authors.forename: Toshihiro
authors.initials: T
authors.lastname: Nukiwa
authors.forename: Kiyoshi
authors.initials: K
authors.lastname: Mori
authors.forename: Masahiro
authors.initials: M
authors.lastname: Tsuboi
authors.forename: Takeshi
authors.initials: T
authors.lastname: Horai
authors.forename: Noriyuki
authors.initials: N
authors.lastname: Masuda
authors.forename: Kenji
authors.initials: K
authors.lastname: Eguchi
authors.forename: Tetsuya
authors.initials: T
authors.lastname: Mitsudomi
authors.forename: Soichiro
authors.initials: S
authors.lastname: Yokota
authors.forename: Yoshihiko
authors.initials: Y
authors.lastname: Segawa
authors.forename: Yukito
authors.initials: Y
authors.lastname: Ichinose
authors.forename: Masahiro
authors.initials: M
authors.lastname: Fukuoka
authors.forename: Nagahiro
authors.initials: N
authors.lastname: Saijo